HUMAN BRAIN NATRIURETIC PEPTIDE (BNP) - ANVISA Registration 81086830104
Access comprehensive regulatory information for HUMAN BRAIN NATRIURETIC PEPTIDE (BNP) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 81086830104 and manufactured by VEDALAB. The registration is held by FASTTEST DISTRIBUIDORA DE PRODUTOS PARA LABORATÓRIOS LTDA with validity until Jun 30, 2035.
This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including SIEMENS HEALTHCARE DIAGNOSTICS INC., ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Related Devices (2)
Registration Details
81086830104
25351035746202541
20037992000139
Company Information
Dates and Status
Jun 30, 2025
30/06/2035
09/18/2025 19:00:01
PEPTÍDEO NATRIURÉTICO CEREBRAL HUMANO (BNP)
ADVIA Centaur NT-proBNPII (PBNPII)
Not specified
10345162547
Sep 15, 2025
PEPTÍDEO NATRIURÉTICO CEREBRAL HUMANO (BNP)
ADVIA Centaur NT-proBNPII (PBNPII)
SIEMENS HEALTHCARE DIAGNOSTICS INC.
10345162547
Sep 15, 2025
PEPTÍDEO NATRIURÉTICO CEREBRAL HUMANO (BNP)
Luminis FIA NT-proBNP
QINGDAO HIGHTOP BIOTECH CO.,LTD.
80474870164
Sep 08, 2025
PEPTÍDEO NATRIURÉTICO CEREBRAL HUMANO (BNP)
Luminis FIA NT-proBNP
Not specified
80474870164
Sep 08, 2025
PEPTÍDEO NATRIURÉTICO CEREBRAL HUMANO (BNP)
Família de Reagentes Finecare NT-proBNP
GUANGZHOU WONDFO BIOTECH CO. LTD
80537410148
Sep 08, 2025

